Immune Pharmaceuticals lists on Nasdaq after reverse merger – Globes

Immune Pharmaceuticals lists on Nasdaq after reverse merger Globes The merged company will be called Immune Pharmaceuticals Inc., and will be listed on Nasdaq and in Stockholm, after EpiCept shareholders approved the merger and a 1:40 reserves stock split last week. EpiCept's share price fell 5.2% on Friday to $ 0.09, …

nasdaq – Google News